A Randomized Phase II Study Comparing Sequential High dose Testosterone and Enzalutamide to Enzalutamide alone in Asymptomatic Men with Castration Resistant Metastatic Prostate Cancer
Categories (click each to see list of all clinical trials associated with that category): GU (ONC)
Current Status: Open
Phase: II (Cancer Control)
Principal Investigator: Teply, Benjamin
Contact Information:
Amanda Redmond
aredmond@unmc.edu
Eligibility: https://clinicaltrials.gov/ct2/show/study/NCT04363164?term=04363164&draw=2&rank=1#eligibility
Summary
The primary objective of the study is to determine if treatment with sequential high dose testosterone and Enza (STE) or variable sequential high dose T/Enza (VSTE) will improve clinical/radiographic progression free survival (crPFS) compared to Enza in asymptomatic men with evidence of progressive metastatic CRPC post-treatment with abiraterone.